Last analyzed: May 28, 2026 (Q4 FY25)
Pharmaceuticals
$44.29
Market Cap
$108M
P/E Ratio
19.195654
Revenue Rank
Rank 4
Margin Rank
Rank 3
Discover more ways to research and analyze Indian stocks